Novo Holdings exits UK's Convatec after discounted share sale, bookrunner says
(Reuters) -Novo Holdings, which controls obesity drugmaker Novo Nordisk, sold its 7.8% stake in Convatec at a discount, exiting its shareholding in the British maker of medical products, a bookrunner for the offering said on Tuesday. Shares in Convatec...
Reuters